URL https://www.reuters.com/resizer/gEOGVMxdjH3i9mfOAwuOO2_MSt0=/960x0/filters:quality(80)/cloudfront-us-east-2.images.arcpublishing.com/reuters/AO3L7DYQEROQHLYAYTQDETWCAM.jpg
URL2 https://www.reuters.com/business/healthcare-pharmaceuticals/us-fda-approves-takedas-blood-disorder-therapy-2023-11-09/
